Jessica Hagen
The funding boosts the Australia-based company's valuation to $465 million and brings its total raise to almost $100 million.
The company said it worked with mental health and teen experts to help chatGPT recognize signs that a teen may be thinking of harming themselves.
The company was sold to an affiliate of New Enterprise Associates and a consortium of investors for $1.465 billion and ceased trading on the NYSE on Oct. 2.
The launch comes a day after General Catalyst CEO Hemant Taneja announced the closing of the firm’s $485 million acquisition of Ohio healthcare system Summa Health.
The funds will be used to expand the company's workforce and accelerate development of its AI-powered patient engagement platform, Assort OS.
Thanks to the deal, Pfizer will avoid upcoming U.S. tariffs on overseas-made drugs for three years by offering discounted medications directly to American consumers.
The partners will study the effectiveness of SpotitEarly's breath-based test for detecting early-stage breast cancer.
The company will trial its AI eye-tracking technology in Antarctica to simulate the harsh conditions of deep space missions.
The company will adapt space-tested health technologies for Earth, including post-operative recovery kits, civilian spaceflight medical systems and longevity medicine tools.
The company will use the funds to scale nationally, broaden partnerships with payers and health systems, and expand into new neurological condition areas.